My watch list
my.yumda.de  
Login  

8 Current news of jennewein-biotechnologie

rss

A milestone for Jennewein Biotechnologie for the GRAS approval of the HMO-mix

09-Jan-2020

Jennewein Biotechnology announces another milestone in the Worldwide approval of a new product generation, the "HMO-Mix". The data of the toxicological study, with the title "A Safety Evaluation of Mixed Human Milk Oligosaccharides in Rats", was recently accepted for publication by the renowned ...

more

image description
Interim status of the clinical study "Growth and Tolerance" by Jennewein Biotechnologie

25-Nov-2019

Jennewein Biotechnologie GmbH, the leading manufacturer of human milk oligosaccharides, initiated its first clinical study in July 2018. The so-called "Growth and Tolerance" study will show that the supplementation of infant food with human milk oligosaccharides (HMOs) is very suitable for ...

more

image description
Cooperation in the field of human milk oligosaccharide research

07-Feb-2019

Jennewein Biotechnologie GmbH, the global leader in the research and manufacture of human milk oligosaccharides (HMO),and Inner Mongolia Yili Industrial Group (Yili Group), China’s leading dairy company, announce today the signing of a Memorandum of Understanding on infant microbiome and human ...

more

image description
Jennewein Biotechnologie GmbH acquires Arthus Mineralsprings Bad Hönningen

Construction of a new, integrated fermentation and recovery plant for human milk oligosaccharides planned

10-Oct-2018

Jennewein Biotechnologie GmbH announces that it has acquired the former facilities of Arthus Mineralspring Company in Bad Hönningen (Rhineland-Palatine) in order to expand the production of human milk oligosaccharides (HMOs). "We have been searching for some time for a suitable location to ...

more

image description
Jennewein Biotechnologie develops new fermentation technology for human milk oligosaccharides and expands its product portfolio

20-Sep-2018

Jennewein Biotechnologie GmbH announces the introduction of a total biosynthesis approach for the production of human milk oligosaccharides (HMOs). Currently the production of HMOs by fermentation requires lactose as a starting material. Lactose is a costly dairy by-product and is difficult to ...

more

EIB provides funding to Jennewein

25-Jul-2018

The European Investment Bank (EIB) provides new financing of EUR 15 million to Jennewein Biotechnologie GmbH, a highly innovative German company that offers a breakthrough technology for the production of rare functional sugars for a wide range of applications, including nutritional, ...

more

image description
First clinical trial of a blend of human milk oligosaccharides emulating the human profile of infant formula

07-May-2018

Jennewein Biotechnologie GmbH announces its first clinical trial of an infant formula that contains human milk oligosaccharides at the concentrations naturally found in human breast milk. Jennewein Biotechnologie is a leading producer of complex oligosaccharides, focusing on human milk ...

more

image description
Jennewein Biotechnologie obtains EU approval for 2’-fucosyllactose

22-Nov-2017

Jennewein Biotechnologie , the world’s leading manufacturer of human milk oligosaccharides (HMOs), today announces that it has received a response from the European Commission which includes the decision that “2'-fucosyllactose powder and liquid concentrate may be placed on the European Union ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE